Trials / Completed
CompletedNCT03289169
Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines
A Single-Arm Trial, Open-label, Repeated, Long-term, Multi-center, A Phase IV Clinical Trial to Evaluate the Long-term Efficacy and Safety of Repeat Treatment With MEDITOXIN® in Treatment of Glabella Line
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the long-term safety of repeated administrations of Meditoxin® in the treatment of moderate to severe glabellar lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MEDITOXIN® | 20U of Meditoxin® is injected to two places on the corrugators muscle for each eye and one place on the procerus muscle, total of 5 sites. |
Timeline
- Start date
- 2016-12-30
- Primary completion
- 2019-05-29
- Completion
- 2019-05-29
- First posted
- 2017-09-20
- Last updated
- 2020-08-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03289169. Inclusion in this directory is not an endorsement.